WO2007115278A3 - 3,6,11-tricyclolide - Google Patents

3,6,11-tricyclolide Download PDF

Info

Publication number
WO2007115278A3
WO2007115278A3 PCT/US2007/065827 US2007065827W WO2007115278A3 WO 2007115278 A3 WO2007115278 A3 WO 2007115278A3 US 2007065827 W US2007065827 W US 2007065827W WO 2007115278 A3 WO2007115278 A3 WO 2007115278A3
Authority
WO
WIPO (PCT)
Prior art keywords
present
compounds
subject
invention further
relates
Prior art date
Application number
PCT/US2007/065827
Other languages
French (fr)
Other versions
WO2007115278A2 (en
Inventor
Ying Sun
Yat Sun Or
Zhe Wang
Original Assignee
Enanta Pharm Inc
Ying Sun
Yat Sun Or
Zhe Wang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enanta Pharm Inc, Ying Sun, Yat Sun Or, Zhe Wang filed Critical Enanta Pharm Inc
Publication of WO2007115278A2 publication Critical patent/WO2007115278A2/en
Publication of WO2007115278A3 publication Critical patent/WO2007115278A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention discloses compounds of formula (I) or pharmaceutically acceptable salts, esters, or prodrugs thereof, which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject in need of antibiotic treatment. The invention also relates to methods of treating a bacterial infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The invention further includes process by which to make the compounds of the present invention.
PCT/US2007/065827 2006-04-04 2007-04-03 3,6,11-tricyclolide WO2007115278A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78891706P 2006-04-04 2006-04-04
US60/788,917 2006-04-04

Publications (2)

Publication Number Publication Date
WO2007115278A2 WO2007115278A2 (en) 2007-10-11
WO2007115278A3 true WO2007115278A3 (en) 2008-10-16

Family

ID=38564300

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/065827 WO2007115278A2 (en) 2006-04-04 2007-04-03 3,6,11-tricyclolide

Country Status (1)

Country Link
WO (1) WO2007115278A2 (en)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
STEFANI: "Stefani Emergence of Multi-Drug Resistance Gram-Positive Bacteria and New Active Antibiotics", CURR. MED. CHEM. - ANTI-INFECTIVE AGENTS, vol. 4, 2005, pages 235 - 257 *

Also Published As

Publication number Publication date
WO2007115278A2 (en) 2007-10-11

Similar Documents

Publication Publication Date Title
TWI327573B (en) 6-11 bicyclic ketolide derivatives
WO2006063039A3 (en) 3, 6-bicyclolides
WO2008154642A3 (en) Antibacterial agents
WO2005000863A3 (en) 6, 11-4c-bicyclic 9a-azalide derivatives
WO2004062601A3 (en) Antibacterial agents
WO2005070113A3 (en) 9n-substituted 6-11 bicyclic erythromycin derivatives
WO2004087728A3 (en) 6,11-3c-bicyclic 9a-azalide derivatives
WO2006039263A3 (en) NOVEL BICYCLIC 9a-AZALIDE DERIVATIVES
UA94901C2 (en) Antibacterial piperidine derivatives
WO2009075923A3 (en) 6, 11-bridged biaryl macrolides
WO2010032147A3 (en) Hydroxamic acid derivatives useful as antibacterial agents
WO2007070598A3 (en) Nucleotide and oligonucleotide prodrugs
WO2006065721A3 (en) 11, 12-lactone bicyclolides
WO2008020227A3 (en) Antibacterial pyrrolecarboxamides
WO2008020229A3 (en) Antibacterial pyrrolecarboxamides
WO2004096823A3 (en) Novel ketolide derivatives
WO2010132765A3 (en) Antibacterial aminoglycoside analogs
CA2483875A1 (en) 6,11 bicyclic erythromycin derivatives
WO2007044927A3 (en) 6, 11-bridged tricyclic macrolides
WO2004096822A3 (en) Pyridyl substituted ketolide antibiotics
WO2006065743A3 (en) Tetracylic bicyclolides
WO2007138112A3 (en) Compounds that interact with ion channels, in particular with ion channels from the kv family
WO2005067564A3 (en) 6-11 bicyclic erythromycin derivatives
WO2008028805A3 (en) Use of a pharmaceutical composition comprising an anticholinergic for killing microorganisms and for treating respiratory tract infections
WO2008014221A3 (en) Bridged carbamate macrolides

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07759994

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07759994

Country of ref document: EP

Kind code of ref document: A2